
Dr. Strati shares about trials happening at MD Anderson for DLBCL and follicular lymphoma. This includes the following:
Two completed follicular lymphoma trials:
Phase I study of evorpacept and R2 in relapsed indolent B-NHL
Phase 2 study of acalabrutinib and R2 in previously untreated indolent B-NHL
One ongoing DLBCL trial:
Phase 2 study of loncastuximab as consolidation after CART in DLBCL
One upcoming DLBCL trial:
Phase 2 study of emapalaumab for the treatment of persistent severe cytopenia after CART in DLBCL